Form 4 · Filed Jun 25, 2026, 08:38 PM UTC
FDMT/4D Molecular Therapeutics, Inc.
Bizily Scott — Chief Legal Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | M | other | 9,810 | $4 | $40,613 | 18,427 |
| Jun 23, 2026 | S | sell | 9,810 | $12 | $117,720 | 8,617 |
| Jun 23, 2026 | M | other | 9,810 | — | — | 63,785 |
Source: SEC EDGAR raw filing ↗ · Accession 0001920738-26-000002